SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950168-02-001140
Filing Date
2002-04-29
Accepted
2002-04-29 17:23:16
Documents
4
Period of Report
2002-02-19
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d8ka.txt 8-K/A 3571
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex232.txt EX-23.2 806
4 AUDITED COMBINED FINANCIAL STATEMENTS dex991.txt EX-99.1 33215
5 PRO FORMA COMBINED FINANCIAL STATEMENTS dex992.txt EX-99.2 20711
  Complete submission text file 0000950168-02-001140.txt   60286
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-27570 | Film No.: 02625325
SIC: 8731 Services-Commercial Physical & Biological Research